EQS-News: MEDICLIN AG / Key word(s): Expansion/Contract MEDICLIN buys Reha-Klinik am Sendesaal 05.04.2024 / 15:09 CET/CEST The issuer is solely responsible for the content of this announcement. MEDICLIN buys Reha-Klinik am Sendesaal
The purchase agreement for the rehabilitation clinic in Bremen was signed today Offenburg, 5 April 2024 – As of today, it’s official: MEDICLIN is buying the Reha-Klinik am Sendesaal, which previously belonged to the Specht Group. The purchase agreement was signed this morning in Bremen. “We warmly welcome the employees of the Reha-Klinik am Sendesaal”, says Dr Joachim Ramming, CEO of MEDICLIN. “Rehabilitation is our core competence and we look forward to shaping the rehabilitation of the future together with the employees in Bremen!” The existing employment relationships are to be retained unchanged. A transfer of operations is planned for the second quarter. Thomas Piefke, COO at MEDICLIN and responsible for the Rehab division, emphasises: “As part of our rehab strategy, we are in the process of expanding our structures in the ambulatory and – where appropriate – stationary areas. The Reha-Klinik am Sendesaal is a very good fit for our Group, both with its specialised areas and its mix of stationary and ambulatory services.” In future, the clinic will be managed by Holger Kammann, who is also Regional Managing Director and Head of the MEDICLIN Hedon Clinic in Lingen. “I’m looking forward to getting to know the staff at the Reha-Klinik am Sendesaal in the coming weeks and months and to travelling the path ahead together,” says Kammann. About the Rehabilitation Clinic at the Sendesaal For further information: MEDICLIN Aktiengesellschaft Investor Relations Public Relations About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510) MEDICLIN ─ a company of the Asklepios Group 05.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Filament Health Corp. To List on Nasdaq Through Business Combination With Jupiter Acquisition Corporation | Psychedelic Invest
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical‐stage natural psychedelic drug development company, and Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter“), a special